COMMUNIQUÉS West-GlobeNewswire
-
Scorpius Holdings, Inc. Announces Closing of Public Offering
19/08/2024 - 19:08 -
TEPKINLY® (epcoritamab) Receives Second European Commission Approval for the Treatment of Adults with Relapsed/Refractory Follicular Lymphoma
19/08/2024 - 20:00 -
Stryker to participate in the 2024 Wells Fargo Healthcare Conference
19/08/2024 - 22:00 -
Kymera Therapeutics Announces Proposed Public Offering
19/08/2024 - 22:01 -
Cocrystal Pharma to Highlight Near-term Clinical Milestones During Presentations at Two Upcoming Investment Conferences
19/08/2024 - 22:05 -
Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights
19/08/2024 - 22:05 -
AEON Biopharma to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024
19/08/2024 - 22:05 -
SciSparc Announces Enrollment of the First Five Patients in the Clinical Trial of its Innovative SCI-210 Treatment
19/08/2024 - 22:11 -
Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.
19/08/2024 - 22:11 -
Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights
19/08/2024 - 22:15 -
Soleno Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
19/08/2024 - 22:17 -
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
16/08/2024 - 23:00 -
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
16/08/2024 - 23:00 -
Cannara Biotech atteint sa part de marché nationale la plus élevée, soit 3,2 %, en juillet 2024 et annonce la tenue d’une webdiffusion pour les investisseurs le 20 août 2024
17/08/2024 - 02:25 -
Bavarian Nordic Provides Statement on Mpox Vaccine Supply and Collaboration with African and Global Stakeholders
17/08/2024 - 13:26 -
UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
17/08/2024 - 17:27 -
Precipio Announces Q2-2024 Shareholder Update Call
15/08/2024 - 23:00 -
Immuron CEO, Steven Lydeamore to present at the Emerging Growth Conference
16/08/2024 - 00:14 -
Bavarian Nordic Submits Data to EMA to Extend Mpox/Smallpox Vaccine Approval to Adolescents
16/08/2024 - 07:30
Pages